Clinical Quality Indicators

Transcription

1 Clinical Quality Indicatrs Patients currently n PrEP Patients currently n PrEP Definitins: Eligibility: Any patient wh has been prescribed PrEP during the review perid. Risk Assessment Prprtin f patients wh received a risk assessment regarding histry f cndm usage, STI, intravenus drug use, transactinal sex, and Nn-ccupatinal Pst-Expsure Prphylaxis (npep) at baseline and every 4 mnths afterwards. All patients Number f patients wh received a risk assessment at least every 4 mnths Risk assessments include: Cndm usage STI histry Intravenus drug use histry Transactinal sex histry Nn-ccupatinal Pst-Expsure Prphylaxis (npep) histry HIV Testing Prprtin f patients wh received an HIV test at baseline and every 4 mnths afterwards. All patients Number f patients wh received an HIV test at baseline and at least every 4 mnths HIV Sercnversin Prprtin f patients wh test psitive fr HIV. All patients wh were tested fr HIV Number f patients wh test psitive fr HIV while n PrEP STI Screening Prprtin f patients wh received a syphilis, gnrrhea, and chlamydia tests at baseline and every 4 mnths. All patients Number f patients wh received syphilis, gnrrhea, and chlamydia tests at baseline and at least every 4 mnths

2 Rectal Chlamydia Testing Prprtin f patients wh received a rectal chlamydia test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal chlamydia at least every 4 mnths Rectal Gnrrhea Testing Prprtin f patients wh received a rectal gnrrhea test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal gnrrhea at least every 4 mnths Pharyngeal Gnrrhea Testing Prprtin f patients wh received a pharyngeal gnrrhea test every 4 mnths. All patients engaging in ral sex Number f patients wh were tested fr pharyngeal gnrrhea at least every 4 mnths Renal Functin Screening Prprtin f patients whse renal functin was assessed fr serum creatinine at baseline and every 6 mnths. All patients Number f patients wh received a serum creatinine test at baseline and every 6 mnths Urinalysis Prprtin f patients wh received a urinalysis at baseline and every 6 mnths. All patients Number f patients wh received a urinalysis at baseline and every 6 mnths Adherence Assessment Prprtin f patients wh received an adherence assessment every 4 mnths. All patients Number f patients wh received an adherence assessment every 4 mnths Mental Health Screening Prprtin f patients wh received a baseline and annual mental health screening. All patients Number f patients wh received a baseline and annual mental health screening

3 Substance Abuse Screening Prprtin f patients wh received a baseline and annual substance abuse screening. All patients Number f patients wh received a baseline and annual substance abuse screening Dmestic Vilence Screening Prprtin f patients wh received a baseline and annual dmestic vilence screening. All patients Number f patients wh received a baseline and annual dmestic vilence screening Linkage t care Prprtin f patients wh sercnverted and were linked t HIV care within 5 days. All patients wh sercnverted Number f patients wh were linked t HIV care within 5 days f sercnversin

4 Patients wh have nt started PrEP Patients wh have nt started PrEP Eligibility: Patients wh have nt been prescribed PrEP but are currently enrlled in the PrEP prgram during the review perid. Risk Assessment Prprtin f patients wh received a risk assessment regarding histry f cndm usage, STI, intravenus drug use, transactinal sex, and Nn-ccupatinal Pst-Expsure Prphylaxis (npep) at baseline and every 4 mnths afterwards. All patients Number f patients wh received a risk assessment at least every 4 mnths Risk assessments include: Cndm usage STI histry Intravenus drug use histry Transactinal sex histry Nn-ccupatinal Pst-Expsure Prphylaxis (npep) histry HIV Testing Prprtin f patients wh received an HIV test every 4 mnths. All patients Number f patients wh received an HIV test at least every 4 mnths HIV Testing: HIV Sercnversin (nt n PrEP) Prprtin f patients testing psitive fr HIV. All patients wh were tested fr HIV Number f patients wh test psitive fr HIV Exclusins: Patients with a knwn HIV infectin. Linkage t care (Sercnversins) Prprtin f patients wh sercnverted and were linked t HIV care within 5 days. All patients wh sercnverted Number f patients wh were linked t HIV care within 5 days f sercnversin STI Screening Prprtin f patients wh received a syphilis, gnrrhea, and chlamydia tests at baseline and every 4 mnths.

5 All patients Number f patients wh received syphilis, gnrrhea, and chlamydia tests at baseline and at least every 4 mnths Rectal Chlamydia Testing Prprtin f patients wh received a rectal chlamydia test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal chlamydia at least every 4 mnths Rectal Gnrrhea Testing Prprtin f patients wh received a rectal gnrrhea test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal gnrrhea at least every 4 mnths Pharyngeal Gnrrhea Testing Prprtin f patients wh received a pharyngeal gnrrhea test every 4 mnths. All patients engaging in ral sex Number f patients wh were tested fr pharyngeal gnrrhea at least every 4 mnths

6 General Clinic-Specific Quality Indicatrs Clinic level Indicatrs Clinic Level Eligibility: Patients are thse wh: Are in a serdiscrdant relatinships Reprt having cndmless sex Had an STI within the past 6 mnths Have injected drugs within the past 6 mnths Identify as transgender and engage in high-risk sex Engage in transactinal sex Have been prescribed nn-ccupatinal pst-expsure prphylaxis (npep). Rutine Offering f PrEP Prprtin f at risk patients wh were ffered PrEP. All patients Number f patients wh were ffered PrEP services Patient Experience Indicatrs Patient Experience Eligibility: All patients enrlled in the PrEP prgram. Patient Experience Prprtin f patients wh were assessed fr experience. All patients Number f patients were assessed fr experience Stigma Prprtin f patients wh reprted experiences f stigma when receiving PrEP services. All patients Number f patients wh reprted experiences f stigma assciated with receiving PrEP services Access t Medicatin Prprtin f patients reprting gaps in medicatin adherence. All patients wh have been prescribed PrEP Number f patients wh reprted gaps in medicatin adherence

7 Organizatinal Metrics Organizatinal Indicatrs Onging Staff Training Staff receiving annual PrEP training. All staff prviding HIV care Number f staff that receive annual PrEP training Stigma Reductin Training Staff receiving annual stigma reductin training. All staff prviding HIV care Number f staff that receive annual stigma reductin training Referral and Linkage Prprtin f patients wh were linked t primary care after stpping PrEP. Patients that have stpped taking PrEP within the review perid Number f patients that are linked and referred t primary care Exclusins: Sites with an integrated PrEP and primary care prgram. Lst t Care Prprtin f patients wh were reengaged in care after missing 2 r mre cnsecutive PrEP clinical appintments. All PrEP patients wh have missed 2 r mre cnsecutive PrEP clinical appintments Number f patients reengaged in care

8 Ppulatin Indicatrs Patients with STIs Prprtin f patients wh test psitive fr STIs. All patients receiving services in a PrEP prgram Number f STIs Incidence rate f STIs fr PrEP patients. All patients receiving services in a PrEP prgram Number f patients wh test psitive fr STIs Number f cnfirmed unique diagnses f STIs Linkage t Care Prprtin f identified PrEP eligible patients wh were linked t PrEP services. Patients wh: Number f patients wh were linked t Are in a serdiscrdant relatinships PrEP services Reprt having cndmless sex Had an STI within the past 6 mnths Have injected drugs within the past 6 mnths Identify as transgender and engage in highrisk sex Engage in transactinal sex Have been prescribed nn-ccupatinal pstexpsure prphylaxis (npep).